[HTML][HTML] Current advances in niosomes applications for drug delivery and cancer treatment
The advent of nanotechnology has led to an increased interest in nanocarriers as a drug
delivery system that is efficient and safe. There have been many studies addressing nano …
delivery system that is efficient and safe. There have been many studies addressing nano …
A state-of-the-art review on the recent advances of niosomes as a targeted drug delivery system
S Yasamineh, P Yasamineh, HG Kalajahi… - International journal of …, 2022 - Elsevier
The buildup of nonionic surfactants in the aqueous environment produces niosomes. The
usage of niosomes is becoming increasingly frequent due to their sustainability, low cost of …
usage of niosomes is becoming increasingly frequent due to their sustainability, low cost of …
Functional ligands for improving anticancer drug therapy: current status and applications to drug delivery systems
R Bajracharya, JG Song, BR Patil, SH Lee, HM Noh… - Drug Delivery, 2022 - Taylor & Francis
Conventional chemotherapy lacking target selectivity often leads to severe side effects,
limiting the effectiveness of chemotherapy. Therefore, drug delivery systems ensuring both …
limiting the effectiveness of chemotherapy. Therefore, drug delivery systems ensuring both …
Niosomes-loaded selenium nanoparticles as a new approach for enhanced antibacterial, anti-biofilm, and anticancer activities
A Haddadian, FF Robattorki, H Dibah, A Soheili… - Scientific reports, 2022 - nature.com
Targeted drug delivery and increasing the biological activity of drugs is one of the recent
challenges of pharmaceutical researchers. Niosomes are one of the new targeted drug …
challenges of pharmaceutical researchers. Niosomes are one of the new targeted drug …
Recent advances in surface modification of micro-and nano-scale biomaterials with biological membranes and biomolecules
MS Abesekara, Y Chau - Frontiers in Bioengineering and …, 2022 - frontiersin.org
Surface modification of biomaterial can improve its biocompatibility and add new
biofunctions, such as targeting specific tissues, communication with cells, and modulation of …
biofunctions, such as targeting specific tissues, communication with cells, and modulation of …
Chitosan-based nanoniosome for potential wound healing applications: Synergy of controlled drug release and antibacterial activity
T Pourseif, R Ghafelehbashi, M Abdihaji… - International Journal of …, 2023 - Elsevier
This study aims to develop a niosomal platform which can delivery drugs such as
tetracycline hydrochloride (TCH) to treat bacterial infections in wounds. To this end, chitosan …
tetracycline hydrochloride (TCH) to treat bacterial infections in wounds. To this end, chitosan …
Modification of poly (glycerol adipate) with tocopherol and cholesterol modulating nanoparticle self-assemblies and cellular responses of triple-negative breast cancer …
J Suksiriworapong, C Achayawat… - Pharmaceutics, 2023 - mdpi.com
This study aimed to fabricate new variations of glycerol-based polyesters by grafting poly
(glycerol adipate)(PGA) with hydrophobic bioactive moieties, tocopherol (TOC), and …
(glycerol adipate)(PGA) with hydrophobic bioactive moieties, tocopherol (TOC), and …
Formulation strategies to overcome amphotericin B induced toxicity
Fungal infection poses a major global threat to public health because of its wide prevalence,
severe mortality rate, challenges involved in diagnosis and treatment, and the emergence of …
severe mortality rate, challenges involved in diagnosis and treatment, and the emergence of …
Molecular masking of synthetic Immunomodulator evokes antitumor immunity with reduced immune tolerance and systemic toxicity by temporal activity recovery and …
HS Shin, S Kim, SM **, YJ Yoo, JH Heo… - Advanced …, 2024 - Wiley Online Library
Activation of the innate immune system counteracts tumor‐induced immunosuppression.
Hence, small molecule‐based toll‐like receptor 7/8 agonists (TLR7/8a), which can modulate …
Hence, small molecule‐based toll‐like receptor 7/8 agonists (TLR7/8a), which can modulate …
Niosomal Bupropion: Exploring Therapeutic Frontiers through Behavioral Profiling
K Harini, SY Alomar, M Vajagathali, S Manoharadas… - Pharmaceuticals, 2024 - mdpi.com
Bupropion (Bup) belongs to the norepinephrine–dopamine reuptake inhibitor (NDRI) class
and it is the only FDA-approved drug of its class for the treatment of major depressive …
and it is the only FDA-approved drug of its class for the treatment of major depressive …